Pharmacodynamics of the glucagon-like peptide-1 receptor agonist lixisenatide in Japanese and Caucasian patients with type 2 diabetes mellitus poorly controlled on sulphonylureas with/without metformin

AIMS: The PDY6797 study evaluated efficacy, safety and pharmacodynamics of lixisenatide in Japanese and Caucasian patients with type 2 diabetes mellitus (T2DM) insufficiently controlled with sulphonylureas with/without metformin. METHODS: This randomized, double-blind, placebo-controlled trial compr...

Descripción completa

Detalles Bibliográficos
Autores principales: Seino, Y, Takami, A, Boka, G, Niemoeller, E, Raccah, D
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2014
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4312941/
https://www.ncbi.nlm.nih.gov/pubmed/24524806
http://dx.doi.org/10.1111/dom.12276

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4312941/
https://www.ncbi.nlm.nih.gov/pubmed/24524806
http://dx.doi.org/10.1111/dom.12276

Ejemplares similares